Thursday, January 27, 2022

28 January 2022 BMD

                             LOCAL MARKET


Our trade results are posted in our FB page. Click link below to access:-
https://www.facebook.com/Futurescoin-1564520737153902/

If you like what we are doing, kindly like and share our page at FB. Follow us at FB for more updates.

 Click here to contact us : https://goo.gl/B6Dccf 



FKLI

Market managed to eke out minor gains on Thursday as continuous buying in selected heavyweights helped to support market.

To subscribe to a real-time signal, email us at futures.coin@gmail.com for details. Sign up today for your February subscription.


Plan A : Attempt long if market trades firmly above 1516 and rebound. Targets are 1527 and 1537.

Plan B : Consider short if market surges but fails to breach above 1527. Targets are 1520 and 1516.




FCPO

FCPO surged up in the afternoon section and continue to move up north. Dalian closed +238 at 9934 while soybean oil traded +0.39 at 64.73. Ringgit strengthen to RM4.19 against the greenback.

To subscribe to a real-time signal, email us at futures.coin@gmail.com for details. Sign up today for your January subscription.


Plan A : Long if market retraced but supported firm above 5485. Targets are 5512 and 5553.

Plan B : Short only if market failed to support above 5485. Targets are 5461 and 5422.





Disclaimer: This information is intended to assist professional investors. News are credit courtesy of Reuters, Nasdaq.com, Bloomberg, CNN, Market Watch, FT.com, the Star online, forbes.com, mining.com and CNBC. The information does not constitute investment advice or an offer to invest or to provide management services and is subject to correction, completion and amendment without notice.As with all investments, there are associated risks and you could lose money investing. Prior to making any investment, a prospective investor should consult with its own investment, accounting, legal and tax advisers to evaluate independently the risks, consequences and suitability of
that investment.     

 

0 comments:

Post a Comment